Showing results (2231-2240 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|August 14, 2020
Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness AnalysisNing Kam, Kanila Perera, Ella Zomer, et al.
Pharmacoeconomics|August 16, 2020
Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision ModelersRisha Gidwani, Louise B Russell
Pharmacoeconomics|August 6, 2020
Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung CancerErik F Blom, Kevin Ten Haaf, Harry J de Koning
Pharmacoeconomics|April 26, 2021
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO StudyBecky Pennington, Abualbishr Alshreef, Laura Flight, et al.
Pharmacoeconomics|April 10, 2023
Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member CountriesPaul Hanly, Marta Ortega Ortega, Alison Pearce, et al.
Pharmacoeconomics|April 18, 2023
The Value of Health in a Cost-Effectiveness Analysis: Theory Versus PracticeBram Wouterse, Pieter van Baal, Matthijs Versteegh, et al.
Pharmacoeconomics|June 10, 2006
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision makingCornelis Boersma, Jarir Atthobari, Ron T Gansevoort, et al.
Pharmacoeconomics|June 10, 2006
The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathyGeorge W Carides, Shahnaz Shahinfar, Erik J Dasbach, et al.
Pharmacoeconomics|June 29, 2006
Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian countryHwee-Lin Wee, Chee-Eng Tan, Su-Yen Goh, et al.
Pharmacoeconomics|June 29, 2006
Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthmaGunnar Johansson, Emma B Andreasson, Per E Larsson, et al.
Pageof 336